Recorded talks about lifespan and psychdelics (in German)

These are the two talks I've been meaning to share for a while but ended up putting off due to my perfectionism. These were recorded in Germany and are unfortunately in German. 

Psychedelic drug research
This is an online lecture given by Marvin Däumichen from the MIND Foundation. Hosted by the local Göttingen skeptics/humanists and myself. Psychdelics and other recreational drugs are making inroads as new therapeutic modalities for mental disorders, in particular psilocybin, LSD, MDMA and ketamin (the latter was recently approved). Marvin focuses specifically on psychedelics, from history to clinical application. We had a really great discussion at the end showing that this topic is really popular with young people. I do tend to agree with his main point, although I am still worried about unblinding and expectational effects in psychedelic trials.

Aging Research - an introduction
This is an online lecture given by myself during a meeting of the local Göttingen skeptics/humanists. It is a very rough introduction to modern aging research and interventional biogerontology. I wasn't particularly well-prepared for it but it was still fun! Hopefully, one day I can record an extended English version of this talk. The main message will be familiar to readers of this blog and many biogerontologists: many organisms have longer lifespan than we do, progress in mouse aging research has been substantial and there are no fundamental laws stopping us from living a couple of decades or centuries longer. On top of that, slowing aging is the most efficient preventative treatment for a host of diseases due to Tauber's paradox, so even if we fail to radically extend lifespan because the problem proves too difficult (and instead lifespan extension will be more modest), any dollar invested in aging research will have extended healthspan and lifespan more than a dollar invested in disease-centric research.